IL1B and synovial sarcoma: A role of interleukin (IL)-1β has been suggested [2], [3], [4] and IL-1 receptor antagonist anakinra was tried successfully in SS on the basis of its efficacy in treating some hereditary autoinflammatory syndromes, especially cryopyrin-associated periodic syndrome [5], [6], [7].